2018 annual financial data
Amphastar Pharmaceuticals 2018 Operating margin
Direct answer
Operating margin was -2.93%.
Operating income was -8,623,000 USD and net income was -5,738,000 USD.
Operating cash flow was 38,191,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 294,666,000 USD
- Operating income
- -8,623,000 USD
- Net income
- -5,738,000 USD
- Operating cash flow
- 38,191,000 USD